A citation-based method for searching scientific literature

Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette. Mov Disord 2012
Times Cited: 273







List of co-cited articles
801 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




The Prevalence of Huntington's Disease.
Michael D Rawlins, Nancy S Wexler, Alice R Wexler, Sarah J Tabrizi, Ian Douglas, Stephen J W Evans, Liam Smeeth. Neuroepidemiology 2016
121
19

Huntington's disease.
Francis O Walker. Lancet 2007
18

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
411
15

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
558
15

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
895
14

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
249
13

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.
Stephen J W Evans, Ian Douglas, Michael D Rawlins, Nancy S Wexler, Sarah J Tabrizi, Liam Smeeth. J Neurol Neurosurg Psychiatry 2013
102
12

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
12


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
526
11

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
11


Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
Nancy S Wexler, Judith Lorimer, Julie Porter, Fidela Gomez, Carol Moskowitz, Edith Shackell, Karen Marder, Graciela Penchaszadeh, Simone A Roberts, Javier Gayán,[...]. Proc Natl Acad Sci U S A 2004
476
11

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
11

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
256
11

The global prevalence of Huntington's disease: a systematic review and discussion.
Sheharyar Sajjad Baig, Mark Strong, Oliver Wj Quarrell. Neurodegener Dis Manag 2016
42
23

Trinucleotide repeat length instability and age of onset in Huntington's disease.
M Duyao, C Ambrose, R Myers, A Novelletto, F Persichetti, M Frontali, S Folstein, C Ross, M Franz, M Abbott. Nat Genet 1993
806
10

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
349
9

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
8

A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
8

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
569
8


Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
533
8

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Maria Björkqvist, Edward J Wild, Jenny Thiele, Aurelio Silvestroni, Ralph Andre, Nayana Lahiri, Elsa Raibon, Richard V Lee, Caroline L Benn, Denis Soulet,[...]. J Exp Med 2008
371
8

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
123
7


Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review.
Nancy S Wexler, Laura Collett, Alice R Wexler, Michael D Rawlins, Sarah J Tabrizi, Ian Douglas, Liam Smeeth, Stephen J Evans. BMJ Open 2016
22
31

Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
Jodi L McBride, Mark R Pitzer, Ryan L Boudreau, Brett Dufour, Theodore Hobbs, Sergio R Ojeda, Beverly L Davidson. Mol Ther 2011
153
6

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
Samuel Frank, Claudia M Testa, David Stamler, Elise Kayson, Charles Davis, Mary C Edmondson, Shari Kinel, Blair Leavitt, David Oakes, Christine O'Neill,[...]. JAMA 2016
99
6

Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.
Yeun Su Choo, Gail V W Johnson, Marcy MacDonald, Peter J Detloff, Mathieu Lesort. Hum Mol Genet 2004
342
6

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
6

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
550
6

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
779
6

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
203
6

Choosing an animal model for the study of Huntington's disease.
Mahmoud A Pouladi, A Jennifer Morton, Michael R Hayden. Nat Rev Neurosci 2013
203
6

Huntington's disease in the United States: Variation by demographic and socioeconomic factors.
Emilie Bruzelius, Joseph Scarpa, Yiyi Zhao, Sanjay Basu, James H Faghmous, Aaron Baum. Mov Disord 2019
13
46

Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.
Erika Carrassi, Maura Pugliatti, Vittorio Govoni, Mariachiara Sensi, Ilaria Casetta, Enrico Granieri. Neuroepidemiology 2017
9
66


Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
Nan Wang, Michelle Gray, Xiao-Hong Lu, Jeffrey P Cantle, Sandra M Holley, Erin Greiner, Xiaofeng Gu, Dyna Shirasaki, Carlos Cepeda, Yuqing Li,[...]. Nat Med 2014
130
5

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
744
5


Diagnostic criteria for Huntington's disease based on natural history.
Ralf Reilmann, Blair R Leavitt, Christopher A Ross. Mov Disord 2014
103
5

HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Simon C Warby, Henk Visscher, Jennifer A Collins, Crystal N Doty, Catherine Carter, Stefanie L Butland, Anna R Hayden, Ichiro Kanazawa, Colin J Ross, Michael R Hayden. Eur J Hum Genet 2011
97
5

Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.
Meera Swami, Audrey E Hendricks, Tammy Gillis, Tiffany Massood, Jayalakshmi Mysore, Richard H Myers, Vanessa C Wheeler. Hum Mol Genet 2009
159
5

The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.
Oliver Quarrell, Kirsty L O'Donovan, Oliver Bandmann, Mark Strong. PLoS Curr 2012
62
8

The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
Chris Kay, Jennifer A Collins, Galen E B Wright, Fiona Baine, Zosia Miedzybrodzka, Folefac Aminkeng, Alicia J Semaka, Cassandra McDonald, Mark Davidson, Steven J Madore,[...]. Am J Med Genet B Neuropsychiatr Genet 2018
24
20

Beyond the brain: widespread pathology in Huntington's disease.
Jorien M M van der Burg, Maria Björkqvist, Patrik Brundin. Lancet Neurol 2009
211
5

Epidemiology of Huntington's disease in Finland.
Jussi O T Sipilä, Marja Hietala, Ari Siitonen, Markku Päivärinta, Kari Majamaa. Parkinsonism Relat Disord 2015
25
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.